公开(公告)号：WO2003068791A3

公开(公告)日：2003-08-21

申请号：PCT/US2003/004130

申请日：2003-02-11

Applicant: ABBOTT LABORATORIES

Inventor： MA, Zhenkun ,  KEYES, Robert ,  DJURIC, Stevan ,  YONG, Hong

IPC: C07H17/08

Abstract: Compounds having activity against methicillin-resistant staphylococcus aureus (MRSA), the compounds having formula (I), and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis and treatment of MRSA infections using the compounds are disclosed.

公开(公告)号：WO2003068791A2

公开(公告)日：2003-08-21

申请号：PCT/US2003/004130

申请日：2003-02-11

Applicant: ABBOTT LABORATORIES

Inventor： MA, Zhenkun ,  KEYES, Robert ,  DJURIC, Stevan ,  YONG, Hong

IPC: C07H17/00

CPC classification number: C07H17/08

Abstract: Compounds having activity against methicillin-resistant staphylococcus aureus (MRSA), the compounds having formula (I), and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis and treatment of MRSA infections using the compounds are disclosed.

Abstract translation: 具有抗甲氧西林抗性金黄色葡萄球菌（MRSA）活性的化合物，具有式（I）的化合物及其前体药物的盐，前体药物和盐，用于制备该方法中使用的化合物和中间体的方法，包含该化合物的组合物和 公开了使用该化合物预防和治疗MRSA感染的方法。